COVID-19-CoronaVirus-Pipeline-therapies-

DelveInsight’s COVID-19 Pipeline Insights report provides a comprehensive outlook of the pipeline therapies that are in different clinical and pre-clinical stages of development, their launch, and how the market is expected to transform in the aftermath across the COVID-19 domain.

The COVID-19 Pipeline Analysis report offers an in-depth analysis of the therapeutics landscape by development stage, product type, route of administration, molecule type, and MOA for COVID-19 emerging therapies. The pipeline report lays down the business opportunities, threats, prospective collaborations, strong competitors, and growth strategies. 

Some of the key highlights from the COVID-19 Pipeline report:

  • The COVID-19 continues to possess a serious public health issue worldwide, however, more than 8 vaccines have been approved for emergency use over the past few months with several therapies in the pipeline, while few of the vaccine trials have been abandoned after insufficient results.
  • At present the clinical management includes infection prevention and control measures. Sometimes, supportive care such as supplemental oxygen and mechanical ventilatory support is also required in some serious cases.
  • Currently, the three main types of COVID-19 vaccines namely mRNA Vaccine, protein subunit vaccines, and vector vaccines are available in the market. Global pharma and biotech companies are actively exploring new potential vaccines with several of the emerging vaccines in the advanced stages.
  • At present, more than 150+ key companies are involved in the development of therapies for the COVID-19 which includes Novavax, Capricor Therapeutics, Imv Inc., AbbVie, Amgen, Synairgen, Maxwell Biosciences, Veru Inc., Galera Therapeutics, Sorrento Therapeutics, Xenothera, RSV Therapeutics, and many others. 
  • Some of the COVID-19 emerging therapies expected to enter the market include MXB-009, DPX COVID 19, CAP-1002, GC4419, Otezla, SNG001, PSC 04, ABBV-47D11, XC221, XAV-19, and several others. 
  • Among the emerging therapies ZyCoV-D, VLA2001, ARCoV, NVX-CoV2373, Corbevax, Vidprevtyn, and Nanocovax are in the most advanced stage (Phase III) stages of vaccine development.

Request for Sample @ COVID-19 Pipeline Insights and Outlook

COVID-19 Pipeline Therapies

  • MXB-009
  • DPX COVID 19
  • CAP-1002
  • GC4419
  • Otezla
  • SNG001
  • PSC 04
  • CPI-006
  • Bucillamine
  • Losmapimod
  • ABBV-47D11

And many more

The List of Emerging therapies is not exhaustive, the complete list will be provided in the final report, visit to know more @ COVID-19 Therapeutics and Drugs Pipeline

Key Companies in the COVID-19 Therapeutics Landscape:

  • Capricor Therapeutics
  • Imv Inc.
  • Kinarus
  • Veru Inc.
  • Novavax
  • AbbVie
  • Amgen
  • Synairgen Research
  • Xenothera
  • Zydus Cadila
  • RSV Therapeutics
  • Maxwell Biosciences
  • Galera Therapeutics
  • Sorrento Therapeutics
  • Corvus Pharmaceuticals
  • Fulcrum Therapeutics
  • Revive Therapeutics

And many others.

COVID-19 Pipeline Therapeutics Assessment

By Product Type

  • Monotherapy
  • Combination Therapy

By Stage

  • Discovery 
  • Pre-clinical
  • Phase I
  • Phase II
  • Phase III
  • Pre-registration 

By Route of Administration

  • Oral
  • Intravenous
  • Inhalation
  • Sub-cutaneous

By Molecule Type

  • Small Molecule 
  • Gene Therapy
  • Stem Cell Therapy 

Targets:

  • Interferon beta-1a
  • P38 mitogen-activated protein kinase
  • Type 4 cyclic nucleotide phosphodiesterase
  • Superoxide dismutase
  • Viral envelope protein

By Mechanism of Action

  • Interferon-beta 1a replacements
  • P38 mitogen-activated protein kinase inhibitors
  • Cell replacements
  • Type 4 cyclic nucleotide phosphodiesterase inhibitors
  • Virus internalization inhibitors
  • Immunostimulants
  • Antioxidants
  • Viral envelope protein inhibitors
  • Angiotensin type 2 receptor agonists

Got queries? Reach out for more information @ COVID-19 Drug Pipeline Assessment 

Scope of the Report

  • Coverage: Global
  • Key Market Players: Novavax, Zydus Cadila, Capricor Therapeutics, Imv Inc., AbbVie, Amgen, Synairgen, Maxwell Biosciences, Kinarus, Galera Therapeutics, Sorrento Therapeutics, Xenothera, RSV Therapeutics, and many others. 
  • Key Pipeline Therapies: MXB-009, DPX COVID 19, CAP-1002, GC4419, Otezla, SNG001, PSC 04, ABBV-47D11, XC221, XAV-19, and several others. 

Table of Content 

1

Report Introduction

2

COVID-19 

3

COVID-19 Current Treatment Patterns

4

COVID-19 – DelveInsight’s Analytical Perspective

5

Therapeutic Assessment

6

COVID-19 Late Stage Products (Phase-III)

7

COVID-19 Mid Stage Products (Phase-II)

8

Early Stage COVID-19 Products (Phase-I)

9

COVID-19 Pre-clinical Products and Discovery Stage Products

10

Inactive Products

11

Dormant Products

12

COVID-19 Discontinued Products

13

COVID-19 Product Profiles

14

COVID-19 Key Companies

15

COVID-19 Key Products

16

Dormant and Discontinued Products

17

COVID-19 Unmet Needs

18

COVID-19 Future Perspectives

19

COVID-19 Analyst Review

20

Appendix

21

Report Methodology

Know more of what’s covered in the COVID-19 Pipeline Assessment report

Key Questions Answered in the COVID-19 Report

  • What are the current options for COVID-19 treatment?
  • How many companies are developing therapies for the treatment of COVID-19? 
  • What are the principal therapies developed by these companies in the industry?
  • How many therapies are developed by each company for the treatment of COVID-19?
  • How many COVID-19 emerging therapies are in early-stage, mid-stage, and late stage of development for the treatment of COVID-19?
  • Out of total pipeline products, how many therapies are given as a monotherapy and in combination with other therapies? 
  • What are the key collaborations (Industry-Industry, Industry-Academia), Mergers and acquisitions, and major licensing activities that will impact the COVID-19 market? 

Request for a Webex demo @ COVID-19 Drug Pipeline and get a walk-through of our report 

Latest Reports
COVID 19 (Novel Coronavirus 19) Therapeutic Pipeline, Vaccines, and Diagnostics Competitive Landscape
DelveInsight’s report on “COVID 19 (Novel Coronavirus 19) Therapeutic Pipeline, Vaccines, and Diagnostics Competitive Landscape” covers a detailed analysis of companies working for the development of drugs and vaccines as well as diagnostics companies are working on developing test kits. The report also proffers a solid foundation to advance further research and analysis into the COVID 19 covering morbidity and mortality.

mRNA Vaccines and Therapeutics Market
DelveInsight’s ‘Global Messenger RNA (mRNA) based Vaccines and Therapeutics Market Insights, Epidemiology, and Market Forecast 2030’ report deliver an in-depth understanding of the mRNA-based Vaccines and Therapeutics, along with its historical and forecasted epidemiology and market trends in North America, Europe, Asia, and ROW (rest of the world).

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market
DelveInsight’s “Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Anti-hypertension Market
DelveInsight’s “Anti-hypertension Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Anti-hypertension market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

Acute Pyelonephritis Market
DelveInsight’s “Acute Pyelonephritis Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Acute Pyelonephritis market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

Corneal Endothelial Dystrophy Market
DelveInsight’s “Corneal Endothelial Dystrophy Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Corneal Endothelial Dystrophy market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

Type 2 Diabetes Market
DelveInsight’s “Type 2 Diabetes Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Type 2 Diabetes market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

Healthcare Blogs By DelveInsight

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.  Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Connect With Us at LinkedIn | Facebook | Twitter

Tags: COVID-19 Pipeline, COVID-19 Drug Pipeline, COVID-19, COVID-19 Therapies

Contact Information:

Shruti Thakur  [email protected]  +1(919)321-6187